Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$319M |
| 2 |
GSK
GSK
|
+$230M |
| 3 |
LO
LORILLARD INC COM STK
LO
|
+$192M |
| 4 |
Verizon
VZ
|
+$174M |
| 5 |
Mastercard
MA
|
+$160M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.08B |
| 2 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$850M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$781M |
| 4 |
Bausch Health
BHC
|
+$466M |
| 5 |
Meta Platforms (Facebook)
META
|
+$407M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 7.58% |
| 2 | Technology | 5.48% |
| 3 | Financials | 4.9% |
| 4 | Energy | 3.61% |
| 5 | Consumer Discretionary | 3.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Blackstone
BX
$110B
| $6.74M | 0.01% |
180,586
+41,668
| +30% | +$1.51M |
|
1327
PUT
Rockwell Automation
ROK
$49B
| $6.71M | 0.01% |
58,300
+52,500
| +905% | +$5.9M |
|
1328
CALL
Neurocrine Biosciences
NBIX
$16.6B
| $6.7M | 0.01% |
171,700
+143,800
| +515% | +$5.14M |
|
|
WX
1329
DELISTED
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
| $6.68M | 0.01% |
175,772
-24,561
| -12% | -$946K |
|
1330
PUT
DuPont de Nemours
DD
$19.2B
| $6.67M | 0.01% |
56,073
-95,048
| -63% | -$11.3M |
|
1331
Opko Health
OPK
$1.02B
| $6.67M | 0.01% |
476,641
-79,950
| -14% | -$1.04M |
|
1332
Principal Financial Group
PFG
$24.3B
| $6.66M | 0.01% |
130,462
-41,733
| -24% | -$2.1M |
|
|
CAM
1333
PUT
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
| $6.65M | 0.01% |
147,800
+52,700
| +55% | +$2.4M |
|
1334
Banco Bilbao Vizcaya Argentaria
BBVA
$156B
| $6.65M | 0.01% |
699,721
-115,775
| -14% | -$1.04M |
|
|
ARUN
1335
CALL
DELISTED
ARUBA NETWORKS, INC.
ARUN
| $6.63M | 0.01% |
276,400
+101,900
| +58% | +$2.05M |
|
1336
Banco Bradesco
BBD
$36.7B
| $6.63M | 0.01% |
1,565,391
+40,334
| +3% | +$198K |
|
1337
CALL
MGM Resorts International
MGM
$11.2B
| $6.62M | 0.01% |
315,300
-4,111,600
| -93% | -$86.1M |
|
1338
CALL
PNC Financial Services
PNC
$101B
| $6.61M | 0.01% |
71,100
-28,800
| -29% | -$2.6M |
|
1339
Arthur J. Gallagher & Co
AJG
$63.6B
| $6.61M | 0.01% |
143,350
+24,615
| +21% | +$1.15M |
|
|
BCR
1340
DELISTED
CR Bard Inc.
BCR
| $6.6M | 0.01% |
39,493
-14,205
| -26% | -$2.44M |
|
|
SLCA
1341
CALL
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $6.59M | 0.01% |
188,300
+152,600
| +427% | +$4.46M |
|
1342
PUT
Lockheed Martin
LMT
$136B
| $6.58M | 0.01% |
32,600
-145,300
| -82% | -$28.7M |
|
1343
PUT
Air Products & Chemicals
APD
$67.6B
| $6.58M | 0.01% |
47,132
-10,810
| -19% | -$1.5M |
|
1344
CALL
Agilent Technologies
A
$41.2B
| $6.58M | 0.01% |
160,400
+43,600
| +37% | +$1.76M |
|
1345
CALL
iShares MSCI South Korea ETF
EWY
$25.7B
| $6.56M | 0.01% |
115,100
-12,900
| -10% | -$728K |
|
1346
CALL
LyondellBasell Industries
LYB
$19.2B
| $6.55M | 0.01% |
75,300
+25,100
| +50% | +$2.11M |
|
1347
PUT
TripAdvisor
TRIP
$1.26B
| $6.53M | 0.01% |
78,700
-28,100
| -26% | -$2.21M |
|
1348
Canadian National Railway
CNI
$76.6B
| $6.51M | 0.01% |
98,613
-11,927
| -11% | -$812K |
|
1349
CALL
CME Group
CME
$94.8B
| $6.5M | 0.01% |
69,200
+9,400
| +16% | +$871K |
|
1350
Sunstone Hotel Investors
SHO
$2.06B
| $6.5M | 0.01% |
406,326
-9,320
| -2% | -$160K |
|
Similar funds
Barclays's Q1 2015 Portfolio in Review
As of Q1 2015, Barclays held 7,637 positions worth $86.7B, down 17% from $104B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays withdrew a net $19.4B in Q1 2015, closing 488 positions and reducing 4,377 holdings. Its most notable exit was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019, an estimated $781M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 7.6% of assets, up from 5.7% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in iPath Pure Beta Broad Commodity ETN worth $55.8M.
- Barclays's largest Q1 2015 buy was iPath Pure Beta Broad Commodity ETN: 1,861,500 shares worth $55.8M.
- Barclays added most to Envision Healthcare Holdings Inc in Q1 2015, an estimated $319M increase.
- Barclays's biggest Q1 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.08B.
- Barclays fully exited iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019 in Q1 2015, selling an estimated $781M.
- Barclays's ten largest holdings make up 25% of its $86.7B portfolio in Q1 2015.
- Barclays opened 330 new positions and closed 488 in Q1 2015.
- Barclays's portfolio value fell 17% quarter-over-quarter to $86.7B.
Based on Barclays's 13F filing for Q1 2015, filed 14 May 2015.